Derek is an IP litigator. His practice focuses on patent and other intellectual property cases across a variety of technologies, with an emphasis on the life sciences.

Derek’s practice encompasses all areas of litigation through trial and appeal, working as lead and Delaware counsel.

Derek has extensive experience with pharmaceutical cases, representing innovator companies in Abbreviated New Drug Application (ANDA) litigation under the Hatch-Waxman Act and biosimilars. Drawing upon his academic background in biochemistry and molecular biology, he also frequently represents companies in areas such as nucleic acid sequencing and genetic analysis.

Education

Harvard Law School, JD, 2005, 
Ethics, Law and Biotechnology (ELAB), president

Stanford University, MS, Biochemistry, 2001

Johns Hopkins University, BA, Biology, 1997

Admissions

  • Delaware, 2005
  • District of Columbia, 2008
  • US District Court for the District of Delaware, 2006
  • US Court of Appeals for the Federal Circuit, 2007
Jump to Page

We use cookies on this website to improve functionality and performance, to analyze traffic to the website, and to enable social media features. By using this site, you agree to our updated Privacy Policy and our Terms of Use.